The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus
- 601 Downloads
As patients with diabetes mellitus are at increased risk of developing tuberculosis, we hypothesized that this susceptibility to mycobacterial infection is due to a defective Th1-cytokine response. To explore this hypothesis, we examined four groups of subjects in Indonesia: 23 patients with tuberculosis, 34 patients with tuberculosis and diabetes, 32 patients with diabetes only and 36 healthy controls. Ex-vivo production of interferon (IFN)γ, tumour necrosis factor-α and interleukin (IL)-1β, 6, 10, -12 and -4 was measured following stimulation with Mycobacterium tuberculosis, Escherichia coli lipopolysaccharide and phytohaemagglutinin. Patients with active tuberculosis were found to have lower IFNγ levels and a higher production of other pro-inflammatory cytokines and IL-4, both in the presence and absence of diabetes. Diabetes patients without tuberculosis, however, showed strongly reduced non-specific IFNγ production, which is essential for inhibition of the initial growth of M. tuberculosis. Our data suggest that a defective non-specific immune response in diabetes may contribute to an increased susceptibility to develop tuberculosis.
KeywordsTuberculosis Cytokine Production Glycaemic Control Diabetic Subject Tuberculosis Sonicate
This study is an indirect result of the project “Immunogenetic basis of susceptibility to and disease manifestations of mycobacterial infectious”, conducted within the ‘Scientific Programme Indonesia Netherlands’ (SPIN) and supported by the Royal Academy of Arts and Sciences (KNAW), Netherlands, and the Poverty Related Infection Oriented Research (PRIOR) funded by NWO-WOTRO. Funding was provided by the KNAW (mobility grant), the Doctor Catharina van Tussenbroek Foundation, the Janssens Foundation, and the Nederlandse Vereniging voor Immunologie (NVVI), all from the Netherlands. We thank Frenita Siagian and Genia Soemitro for their efforts in subject management and obtaining blood samples. We also extend our gratitude to Dr. Halim Danusantoso and the staff from the Indonesian Tuberculosis Control Association, Jakarta Branch, Indonesia, and Prof. Sangkot Marzuki, director of the Eijkman Institute of Molecular Biology, Jakarta, for their kind support in this collaborative project.
- 17.Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K et al. (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139(1):57–64PubMedCrossRefGoogle Scholar
- 18.Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H (2007) Tuberculosis Susceptibility of Diabetic Mice. Am J Respir Cell Mol Biol. DOI 10.1165/rcmb.2006-0478OC [Epublication ahead of print]
- 19.Word Health Organization (2002) Definition, diagnosis and classification of diabetes mellitus and its complications. Report no. WHO/NCD/NCS/99.2. Department of Noncommunicable Disease Surveillance, World Health Organization, Geneva, pp 48–49Google Scholar
- 20.Falk A, O’Connor JB, Pratt PC (1969) Classification of pulmonary tuberculosis. In: Diagnosis standards and classification of tuberculosis, vol 6, 12th edn. National Tuberculosis and Respiratory Disease Association, New York, pp 68–76Google Scholar
- 31.Netea MG, Stuyt RJ, Kim SH, Van der Meer JW, Kullberg BJ, Dinarello CA (2002) The role of endogenous interleukin (IL)-18, IL-12, IL-1beta, and tumor necrosis factor-alpha in the production of interferon-gamma induced by Candida albicans in human whole-blood cultures. J Inf Dis 185(7):963–970CrossRefGoogle Scholar